Bacille Calmette-Guérin-vaccination kan muligvis sænke den generelle sygelighed hos børn

Thomas Nørrelykke Nissen, Lisbeth Marianne Thøstesen, Nina Marie Birk, Gitte Pihl, Jesper Kjærgaard, Lone Graff Stensballe

Abstract

For almost 100 years the bacille Calmette-Guérin (BCG) vaccine has been the primary prophylaxis of tuberculosis (TB). Recent studies suggest that reintroduction of the vaccine might be beneficial from a general child health perspective. Studies from West-Africa report that BCG vaccination at birth reduces child mortality and morbidity. We recently started "The Calmette Study" in Denmark to conduct a randomised clinical trial and collect firm evidence of the suggested hypothesis, that BCG vaccination at birth has beneficial unspecific effect on child health also in a high-income TB low-incidence country.

Bidragets oversatte titelThe bacille Calmette-Guérin vaccine may reduce the general child morbidity.
OriginalsprogDansk
TidsskriftUgeskrift for læger [online]
Vol/bind176
Udgave nummer9
ISSN1603-6824
StatusUdgivet - 28 apr. 2014

Fingeraftryk

Dyk ned i forskningsemnerne om 'Bacille Calmette-Guérin-vaccination kan muligvis sænke den generelle sygelighed hos børn'. Sammen danner de et unikt fingeraftryk.

Citationsformater